New research published in Value in Health, the International Society for Pharmacoeconomics and Outcomes Research’s official journal, shows cheaper generic drugs are at a higher risk of drug shortages.
The report, “Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study,” was published in the November issue.
“In this study, we were able to characterize for the first time the secular trends of drug shortages in generic drugs, identify the predictors of drug shortages, and link drug shortages to changes in generic drug prices,” Brigham and Women’s Hospital’s Chintan Dave, the author, said.
According to a press release, the study looked at 1.3 billion prescription records between 2008-2014.
To read the study on ISPOR’s website, click here.